<Back to current news

Press Release - for immediate release

03 January 2009

Cellectricon Collaborates With The Automation Partnership to Bring Next
Generation Ion Channel Screening System to Market

Cellectricon, a leading provider of screening solutions for drug discovery, and The Automation Partnership (TAP), manufacturers of advanced automated systems for cell culture, sample management and high throughput screening applications today announced the signing of a collaborative agreement . Under the agreement TAP will co-develop and manufacture the Dynaflow HT System, Cellectricon's
next generation high throughput ion channel screening platform. Dynaflow HT
will be launched and commercially available in 2009.

This latest agreement draws on TAP's proven expertise across applications, engineering and project management. Over the last 20 years, the company has successfully installed many custom automation projects to a number of major pharma companies, across a range of life science disciplines.

"We are excited to partner with TAP who are world-renowned for
manufacturing industrial quality automation," says Jonas Ohlsson, CEO at
Cellectricon. "To bring this fully automated state-of-the-art high throughput
electrophysiology system to the market is a milestone for ion channel
screening. The system offers unmatched throughput, cost per data point and
reliability/predictability."

"The Automation Partnership (TAP) are very pleased to have the
opportunity to work with Cellectricon in automating their unique high
throughput microfluidic screening platform," says Andy Morffew Chief
Executive Officer. "We are looking forward to supporting this system with a
wide range of excellent technical and professional services, designed to
ensure customers gain optimum return from their capital investment."

For further information, please contact:

York Way, Royston, Hertfordshire, SG8 5WY, UK
Tel: +44 1763 227200 Fax: +44 1763 227201

<Back to current news